Johannes Hulthe

Johannes Hulthe

Director/Board Member presso GUARD THERAPEUTICS INTERNATIONAL AB

54 anni
Commercial Services
Health Technology
Consumer Services

Profilo

Dr. Johannes Hulthe, MD, is an Independent Director at Lipigon Pharmaceuticals AB, an Independent Director at Guard Therapeutics International AB, a Chairman at Antaros Renostic AB and a Chief Executive Officer & Director at Antaros Medical AB.
He is on the Board of Directors at Lipigon Pharmaceuticals AB, Guard Therapeutics International AB, Antaros Medical AB, Antaros Holding AB and Metynex Pharmaceuticals AB.
Dr. Hulthe was previously employed as a Vice President by AstraZeneca AB.
He received his graduate degree from the University of Gothenburg and a doctorate degree from the University of Gothenburg.

Posizioni attive di Johannes Hulthe

SocietàPosizioneInizio
GUARD THERAPEUTICS INTERNATIONAL AB Director/Board Member 29/05/2019
LIPIGON PHARMACEUTICALS AB Director/Board Member 01/01/2020
Founder -
Antaros Renostic AB Chairman -
Antaros Holding AB Director/Board Member -
Metynex Pharmaceuticals AB Director/Board Member -
Tutte le posizioni attive di Johannes Hulthe

Precedenti posizioni note di Johannes Hulthe

SocietàPosizioneFine
Corporate Officer/Principal 01/01/2014
Vedi nel dettaglio l'esperienza di Johannes Hulthe

Formazione di Johannes Hulthe

University of Gothenburg Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Johannes Hulthe

Relazioni

23

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
GUARD THERAPEUTICS INTERNATIONAL AB

Health Technology

LIPIGON PHARMACEUTICALS AB

Health Technology

Aziende private5

Commercial Services

Commercial Services

Antaros Renostic AB

Antaros Holding AB

Metynex Pharmaceuticals AB

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Johannes Hulthe